Cognito Therapeutics
Cognito Therapeutics announced healthcare industry veteran Christian Howell joined its team as chief commercial officer.
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
Also: NeuroFlow teams up with the Independence Blue Cross Foundation and Trinity Health Mid-Atlantic to provide its mental health software to frontline healthcare workers.
The startup will now move onto a larger pivotal trial of the neuromodulation therapy, which received a Breakthrough Device Designation from the FDA in January.